Hemorrhagic Cystitis in the Critically Ill Cancer Patient

  • Chukwuma O. Kalu
  • Ala AbudayyehEmail author
Reference work entry


Cancer patients are at increased risk for cystitis due to primary bladder cancer, metastatic disease, infectious etiology due to immunosuppression, or chemical induced due to antineoplastic treatments or radiation induced. Patients at increased risk are ones receiving high dose chemotherapies such as stem cell transplant recipients. We will present urological complications in cancer patients with the associated risk factors, preventative measures, treatments, and outcomes. Morbidity and mortality associated with cancer treatments is further escalated when hemorrhagic cystitis ensues.


Hematopoietic cell transplantation Stem cell transplantation Quality of life Allogeneic transplantation Hemorrhagic cystitis BK virus Hyperbaric oxygen Bladder dysfunction Platelet engraftment 


  1. 1.
    Abudayyeh A, Hamdi A, Lin H, et al. Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients. Am J Transplant. 2016;16(5):1492–502.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Abudayyeh A, Hamdi A, Abdelrahim M, et al. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017;19(1):e12632.CrossRefGoogle Scholar
  3. 3.
    Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(9):1325–30.CrossRefGoogle Scholar
  4. 4.
    Arthur RR, Shah KV, Baust SJ, et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med. 1986;315(4): 230–4.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Asano Y, Kanda Y, Ogawa N, et al. Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32(12):1175–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Ashrani AA, Gabriel DA, Gajewski JL, et al. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant. 2006;38(12): 825–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Atkinson K, Biggs JC, Golovsky D, et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant. 1991;7(5):351–4.PubMedGoogle Scholar
  8. 8.
    Basara N, Rasche FM, Schwalenberg T, et al. Hydronephrosis resulting from bilateral ureteral stenosis: a late complication of Polyoma BK virus cystitis? J Transplant. 2010;2010:1–6.CrossRefGoogle Scholar
  9. 9.
    Bassi PF, Costantini E, Foley S, et al. Glycosaminoglycan therapy for bladder diseases: emerging new treatments. Eur Urol Suppl. 2011;10(6):451–9.CrossRefGoogle Scholar
  10. 10.
    Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol Off J Am Soc Clin Oncol. 1995;13(5):1103–9.CrossRefGoogle Scholar
  11. 11.
    Bhaskaran S, Abu-Arja RF, Abusin G, et al. Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014;49(12):1550–1.CrossRefPubMedGoogle Scholar
  12. 12.
    Blyth E, Clancy L, Simms R, et al. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Transplantation. 2011;92(10):1077–84.CrossRefPubMedGoogle Scholar
  13. 13.
    Bogdanovic G, Priftakis P, Giraud G, et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol. 2004;42(11): 5394–6.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Bogris SL, Johal NS, Hussein I, et al. Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature. J Pediatr Hematol Oncol. 2009;31(4):285–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Brown RB. A method of management of inoperable carcinoma of the bladder. Br J Urol. 1968;40(4):489.PubMedGoogle Scholar
  16. 16.
    Cesaro S, Brugiolo A, Faraci M, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant. 2003;32(9):925–31.CrossRefPubMedGoogle Scholar
  17. 17.
    Cesaro S, Facchin C, Tridello G, et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41(4):363–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Cheuk DK, Lee TL, Chiang AK, et al. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation. Transpl Int. 2007;20(1):73–81.CrossRefPubMedGoogle Scholar
  19. 19.
    Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology. 2005;65(4): 649–53.CrossRefPubMedGoogle Scholar
  20. 20.
    Comoli P, Basso S, Azzi A, et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol. 2003;14(12):3197–204.CrossRefPubMedGoogle Scholar
  21. 21.
    Comoli P, Basso S, Labirio M, et al. T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant. Blood Cells Mol Dis. 2008;40(1):68–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813–26.CrossRefPubMedGoogle Scholar
  23. 23.
    Cox PJ. Cyclophosphamide cystitis – identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28(13):2045–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Czibere A, Bruns I, Graef T, et al. Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2007;13(7):872–4.CrossRefGoogle Scholar
  25. 25.
    Dautruche A, Delouya G. A contemporary review about the management of radiation-induced hemorrhagic cystitis. Curr Opin Support Palliat Care. 2018;12(3):344–50.CrossRefPubMedGoogle Scholar
  26. 26.
    Davis M, Macdonald H, Sames C, et al. Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen. N Z Med J. 2011;124(1340):48–54.PubMedGoogle Scholar
  27. 27.
    Denton AS, Clarke NW, Maher EJ. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. 2002;2002(3):CD001773.Google Scholar
  28. 28.
    El-Zimaity M, Saliba R, Chan K, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004;103(12): 4674–80.CrossRefPubMedGoogle Scholar
  29. 29.
    Fair WR. Formalin in the treatment of massive bladder hemorrhage. Techniques, results, and complications. Urology. 1974;3(5):573–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Ferry C, Socie G. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Exp Hematol. 2003;31(12):1182–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Garderet L, Bittencourt H, Sebe P, et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation. 2000;70(12): 1807–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Gardner SD. Prevalence in England of antibody to human polyomavirus (B.k.). Br Med J. 1973;1(5845): 77–8.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Gatti RA, Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2(7583): 1366–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Gerdemann U, Keirnan JM, Katari UL, et al. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol Ther J Am Soc Gene Ther. 2012;20(8):1622–32.CrossRefGoogle Scholar
  35. 35.
    Gilis L, Morisset S, Billaud G, et al. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014;49(5):664–70.CrossRefPubMedGoogle Scholar
  36. 36.
    Gine E, Rovira M, Real I, et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant. 2003;31(10):923–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Giraud G, Bogdanovic G, Priftakis P, et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica. 2006;91(3):401–4.PubMedGoogle Scholar
  38. 38.
    Goswami AK, Mahajan RK, Nath R, et al. How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol. 1993;149(2):264–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Hadjibabaie M, Alimoghaddam K, Shamshiri AR, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol. 2008;26(1):43–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Han TT, Xu LP, Liu DH, et al. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2014;89(1):55–61.CrossRefPubMedGoogle Scholar
  41. 41.
    Harkensee C, Vasdev N, Gennery AR, et al. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation – a systematic review and evidence-based guidance for clinical management. Br J Haematol. 2008;142(5):717–31.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Heath JA, Mishra S, Mitchell S, et al. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant. 2006;37(5):523–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2010;115(5):925–35.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41(3):354–60.CrossRefGoogle Scholar
  45. 45.
    Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.CrossRefPubMedGoogle Scholar
  46. 46.
    Holler K, Fabeni L, Herling M, et al. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2017;99(2):133–40.CrossRefPubMedGoogle Scholar
  47. 47.
    Ippoliti C, Przepiorka D, Mehra R, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995;46(6):811–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Kaplan JR, Wolf JS. Efficacy and survival associated with cystoscopy and clot evacuation for radiation or cyclophosphamide induced hemorrhagic cystitis. J Urol. 2009;181(2):641–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Karimi M, Zakerinia M, Khojasteh HN, et al. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost. 2004;2(10):1853–5.CrossRefPubMedGoogle Scholar
  50. 50.
    Keles I, Bozkurt MF, Cemek M, et al. Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna. Int Urol Nephrol. 2014;46(12):2301–10.CrossRefPubMedGoogle Scholar
  51. 51.
    Khan H, Oberoi S, Mahvash A, et al. Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2011;17(10):1551–5.CrossRefGoogle Scholar
  52. 52.
    Koc S, Hagglund H, Ireton RC, et al. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2000;26(8):899–901.CrossRefPubMedGoogle Scholar
  53. 53.
    Kwon HJ, Kang JH, Lee JW, et al. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience. Transpl Infect Dis. 2013;15(6):569–74.CrossRefPubMedGoogle Scholar
  54. 54.
    La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(6):871–6.CrossRefGoogle Scholar
  55. 55.
    Lam W, Storek J, Li H, et al. Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning. Transpl Infect Dis. 2017;19(3):e12677.CrossRefGoogle Scholar
  56. 56.
    Le Guenno G, Mahr A, Pagnoux C, et al. Incidence and predictors of urotoxic adverse events in cyclophosphamide- treated patients with systemic necrotizing vasculitides. Arthritis Rheum. 2011;63(5):1435–45.CrossRefPubMedGoogle Scholar
  57. 57.
    Leen AM, Myers GD, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12(10):1160–6.CrossRefPubMedGoogle Scholar
  58. 58.
    Leen AM, Bollard CM, Mendizabal AM, et al. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013;121(26):5113–23.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Leung AY, Mak R, Lie AK, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002;29(6): 509–13.CrossRefPubMedGoogle Scholar
  60. 60.
    Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014;192(6): 1687–92.CrossRefPubMedGoogle Scholar
  61. 61.
    Liu YK, Harty JI, Steinbock GS, et al. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol. 1990;144(1):41–3.CrossRefPubMedGoogle Scholar
  62. 62.
    Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol. 1994;151(5):1348–50.CrossRefPubMedGoogle Scholar
  63. 63.
    Mohamad Al-Ali B, Trummer H, Shamloul R, et al. Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? Urol Int. 2010;84(4):467–70.CrossRefPubMedGoogle Scholar
  64. 64.
    Mohty M, Malard F, Savani BN. High-dose Total body irradiation and Myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink? Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2015;21(4):620–4. Epub 2014 Sep 20.
  65. 65.
    Monach PA, Arnold LM, Merkel PA. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum. 2010;62(1):9–21.CrossRefPubMedGoogle Scholar
  66. 66.
    Mori Y, Miyamoto T, Kato K, et al. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2012;18(3):458–65.CrossRefGoogle Scholar
  67. 67.
    Moro JC, Junior ESB, Riccetto CLZ, et al. Fulminating hemorrhagic cystitis: new trends from etiology to treatment. Curr Bladder Dysfunct Rep. 2015;10(3):212–21.CrossRefGoogle Scholar
  68. 68.
    Mougin J, Souday V, Martin F, et al. Evaluation of hyperbaric oxygen therapy in the treatment of radiation-induced hemorrhagic cystitis. Urology. 2016;94:42–6.CrossRefPubMedGoogle Scholar
  69. 69.
    Nakada T, Nakada H, Yoshida Y, et al. Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study. Urol Int. 2012;89(2):208–14.CrossRefPubMedGoogle Scholar
  70. 70.
    Ordemann R, Naumann R, Geissler G, et al. Encouraging results in the treatment of haemorrhagic cystitis with estrogen – report of 10 cases and review of the literature. Bone Marrow Transplant. 2000;25(9): 981–5.CrossRefPubMedGoogle Scholar
  71. 71.
    Oshrine B, Bunin N, Li Y, et al. Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19(12):1702–7.CrossRefGoogle Scholar
  72. 72.
    Ostroff EB, Chenault OW Jr. Alum irrigation for the control of massive bladder hemorrhage. J Urol. 1982;128(5):929–30.CrossRefPubMedGoogle Scholar
  73. 73.
    Palandri F, Bonifazi F, Rossi C, et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant. 2005;35(5):529–30.CrossRefPubMedGoogle Scholar
  74. 74.
    Payne H, Adamson A, Bahl A, et al. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013;112(7):885–97.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Pihusch M, Bacigalupo A, Szer J, et al. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost. 2005;3(9):1935–44.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Pitto CM, Garcia-Perdomo HA. Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis. Support Care Cancer. 2017;25(7):2043–6.CrossRefPubMedGoogle Scholar
  77. 77.
    Riddell SR, Watanabe KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257(5067):238–41.CrossRefPubMedGoogle Scholar
  78. 78.
    Rigaud J, Hetet JF, Bouchot O. Management of radiation cystitis. Prog Urol. 2004;14(4):568–72.PubMedGoogle Scholar
  79. 79.
    Rorije NM, Shea MM, Satyanarayana G, et al. BK virus disease after allogeneic stem cell transplantation: a cohort analysis. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2014;20(4):564–70.CrossRefGoogle Scholar
  80. 80.
    Savona MR, Newton D, Frame D, et al. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;39(12): 783–7.CrossRefPubMedGoogle Scholar
  81. 81.
    Seber A, Shu XO, Defor T, et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant. 1999;23(1):35–40.CrossRefPubMedGoogle Scholar
  82. 82.
    Shakiba E, Yaghobi R, Ramzi M. Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Exp Clin Transplant. 2011;9(6):405–12.PubMedGoogle Scholar
  83. 83.
    Shepherd JD, Pringle LE, Barnett MJ, et al. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol Off J Am Soc Clin Oncol. 1991;9(11):2016–20.CrossRefGoogle Scholar
  84. 84.
    Shoskes DA, Radzinski CA, Struthers NW, et al. Aluminum toxicity and death following intravesical alum irrigation in a patient with renal impairment. J Urol. 1992;147(3):697–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Silva Lde P, Patah PA, Saliba RM, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010;95(7):1183–90.CrossRefPubMedGoogle Scholar
  86. 86.
    Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14–21.CrossRefPubMedGoogle Scholar
  87. 87.
    Tirindelli MC, Flammia G, Sergi F, et al. Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. Transfusion. 2009;49(1):170–5.CrossRefPubMedGoogle Scholar
  88. 88.
    Tirindelli MC, Flammia GP, Bove P, et al. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2014;20(10):1612–7.CrossRefGoogle Scholar
  89. 89.
    Trotman J, Nivison-Smith I, Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant. 1999;23(8):797–801.CrossRefPubMedGoogle Scholar
  90. 90.
    Turkeri LN, Lum LG, Uberti JP, et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol. 1995;153(3 Pt 1):637–40.PubMedGoogle Scholar
  91. 91.
    Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortes E, et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1999;24(12): 1307–10.CrossRefPubMedGoogle Scholar
  92. 92.
    Vicente J, Rios G, Caffaratti J. Intravesical formalin for the treatment of massive hemorrhagic cystitis: retrospective review of 25 cases. Eur Urol. 1990;18(3): 204–6.CrossRefPubMedGoogle Scholar
  93. 93.
    Vose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol Off J Am Soc Clin Oncol. 1993;11(7):1306–10.CrossRefGoogle Scholar
  94. 94.
    Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333(16):1038–44.CrossRefPubMedGoogle Scholar
  95. 95.
    Wang CC, Weng TI, Wu ET, et al. Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide. Toxicol Sci Off J Soc Toxicol. 2013;131(1):302–10.CrossRefGoogle Scholar
  96. 96.
    Weist BJ, Schmueck M, Fuehrer H, et al. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203(6):395–408.CrossRefPubMedGoogle Scholar
  97. 97.
    Wingard JR, Majhail NS, Brazauskas R, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Am Soc Clin Oncol. 2011;29(16):2230–9.Google Scholar
  98. 98.
    Zwaans BMM, Lamb LE, Bartolone S, et al. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. Int Urol Nephrol. 2018;50(10):1745–1751. Epub 2018 Aug 21.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.UTHealth and MD Anderson Cancer CenterHoustonUSA
  2. 2.Division of Internal Medicine, Section of NephrologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations